Bioseutica's member company, Neova Technologies Inc., produces purified enzymes extracted from government-certified pork pancreas glands. These enzymes are naturally occurring pancreatic proteins that play an important role in the digestion of food. The two main enzymes, trypsin and chymotrypsin, are refined and blended to meet different functional requirements as determined in consultation with customers. A third enzyme offered is phospholipase A2 (PA2). Neova Technologies Inc. (Neova) is one of the world`s largest manufacturers of porcine derived enzymes and has been active in the pancreatic enzyme market for over fifteen years. Products include trypsin/chymotrypsin preparations as well as phospholipase A2 . Market sectors include food, nutraceuticals and pharmaceuticals.
Trypsin and Chymotrypsin are classified as serine proteases, with specific cleaving characteristics. Trypsin preferentially hydrolyzes bonds whose carboxyl groups are contributed by lysine (Lys) or arginine (Arg).Chymotrypsin hydrolyzes peptide bonds involving phenylalanine (Phe), tyrosine (Tyr) and tryptophan (Try). Phospholipase (PA2) is a standardized product, which cleaves the fatty acid at the second position in phospholipids. Pancreatic enzymes effectively hydrolyze a variety of proteins and lipids, using the same natural process as the human digestive system.
- For more detailed information, please visit us at www.neovatech.com.